We assessed GAD67, GluA1 and NR1 protein levels in the hippocampus, striatum and prefrontal cortex (PFC) as an index of glutamatergic and GABAergic function in schizophrenia-relevant brain regions to determine neurochemical consequences of chronic adolescent CBD treatment. The gene discussed is GRIA1; the disease is red-green color blindness.